6-(4-(1-(4-hydroxycyclohexyl)-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one;3,4-Dihydro-6-[4-[1-(4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone; OPC 13213;
Cilostazol Metabolite (OPC-13213) is a fully characterized chemical compound used as a reference standard of API Cilostazol. The standard offered is compliant with regulatory guidelines. Cilostazol Metabolite (OPC-13213) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 87153-04-06
